Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?

scientific article published in February 2003

Pharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable? is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1029810297
P356DOI10.1023/A:1022367311529
P698PubMed publication ID12652173

P2093author name stringPanos E Vardas
George E Kochiadakis
Nikolaos E Igoumenidis
Hercules E Mavrakis
Emmanuel G Manios
Emmanuel M Kanoupakis
P2860cites workChemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapyQ32033393
Evidence-based analysis of amiodarone efficacy and safetyQ33771489
Amiodarone: ionic and cellular mechanisms of action of the most promising class III agentQ33777249
High-density mapping of electrically induced atrial fibrillation in humansQ34727687
Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptorsQ35225966
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmiasQ35313411
Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled studyQ35567061
Method and theory of monophasic action potential recordingQ37712936
Endocardial monophasic action potentials. Correlations with intracellular electrical activityQ37973107
Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugsQ40377415
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardiaQ40692991
Cellular electropharmacology of amiodaroneQ40888033
Intravenous amiodaroneQ41459856
Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapyQ42229679
Drug interactions with amiodaroneQ42241981
A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interactionQ45172101
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.Q45985183
Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodaroneQ46989385
Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values.Q52375946
Electrophysiological mechanisms underlying rate-dependent changes of refractoriness in normal and segmentally depressed canine Purkinje fibers. The characteristics of post-repolarization refractoriness.Q54432956
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines aQ56987002
A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patientQ64763058
Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutterQ68142631
Amiodarone in the management of refractory atrial fibrillationQ68186769
AmiodaroneQ68930408
Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atriumQ69258719
Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effectsQ69637324
Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metaboliteQ69688204
Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardiaQ70577599
Frequency-dependent electrophysiologic effects of amiodarone in humansQ72885808
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation InvestigatorsQ73594702
P433issue1
P921main subjectamiodaroneQ410061
atrial fibrillationQ815819
cardioversionQ1729126
P304page(s)19-26
P577publication date2003-02-01
P1433published inJournal of Interventional Cardiac ElectrophysiologyQ5271168
P1476titlePharmacological cardioversion of recent onset atrial fibrillation with intravenous amiodarone in patients receiving long-term amiodarone therapy: is it reasonable?
P478volume8

Reverse relations

Q22306351ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillationcites workP2860

Search more.